About
EditCo provides high-efficiency CRISPR gene editing services and reagents, specializing in engineered cell lines including immortalized, iPS, primary T cells, and fibroblasts for research and therapeutic development.
Explore EditCo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.